Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$84.49
-0.5%
$99.02
$81.97
$139.06
$147.13B0.6513.72 million shs12.91 million shs
The Beauty Health Company stock logo
SKIN
Beauty Health
$0.64
-4.9%
$0.94
$0.55
$2.69
$83.42M1.121.25 million shs775,742 shs
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Abbott Laboratories stock logo
ABT
Abbott Laboratories
-0.37%+0.30%-16.80%-24.98%-34.23%
The Beauty Health Company stock logo
SKIN
Beauty Health
-4.90%+10.98%-33.64%-38.11%-56.51%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$84.49
-0.5%
$99.02
$81.97
$139.06
$147.13B0.6513.72 million shs12.91 million shs
The Beauty Health Company stock logo
SKIN
Beauty Health
$0.64
-4.9%
$0.94
$0.55
$2.69
$83.42M1.121.25 million shs775,742 shs
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Abbott Laboratories stock logo
ABT
Abbott Laboratories
-0.37%+0.30%-16.80%-24.98%-34.23%
The Beauty Health Company stock logo
SKIN
Beauty Health
-4.90%+10.98%-33.64%-38.11%-56.51%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Abbott Laboratories stock logo
ABT
Abbott Laboratories
2.88
Moderate Buy$119.4341.36% Upside
The Beauty Health Company stock logo
SKIN
Beauty Health
2.00
Hold$2.32260.42% Upside

Current Analyst Ratings Breakdown

Latest ABT and SKIN Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/1/2026
The Beauty Health Company stock logo
SKIN
Beauty Health
Lower Price TargetHold$1.50 ➝ $1.00
4/27/2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Reiterated RatingBuy$131.00
4/24/2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
DowngradeHold (C)Hold (C-)
4/22/2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
DowngradeOutperformNeutral$92.00
4/21/2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Lower Price TargetBuy$140.00 ➝ $125.00
4/21/2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Lower Price TargetMarket Perform$119.00 ➝ $106.00
4/20/2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Lower Price TargetBuy$158.00 ➝ $135.00
4/20/2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Lower Price TargetOverweight$144.00 ➝ $143.00
4/17/2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Lower Price TargetOutperform$135.00 ➝ $130.00
4/17/2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Lower Price TargetOutperform$125.00 ➝ $110.00
4/17/2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Lower Price TargetOutperform$134.00 ➝ $120.00
(Data available from 5/16/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$44.33B3.32$6.99 per share12.08$30.26 per share2.79
The Beauty Health Company stock logo
SKIN
Beauty Health
$300.80M0.28$0.15 per share4.21$0.43 per share1.50
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$6.52B$3.5723.6713.941.4113.90%17.62%10.01%7/16/2026 (Estimated)
The Beauty Health Company stock logo
SKIN
Beauty Health
-$9.52M-$0.17N/AN/AN/A-2.03%-9.38%-1.21%N/A

Latest ABT and SKIN Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/7/2026Q1 2026
The Beauty Health Company stock logo
SKIN
Beauty Health
-$0.09-$0.05+$0.04-$0.05$66.28 million$64.91 million
4/16/2026Q1 2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$1.14$1.15+$0.01$0.61$10.99 billion$11.16 billion
3/12/2026Q4 2025
The Beauty Health Company stock logo
SKIN
Beauty Health
-$0.07-$0.06+$0.01-$0.06$78.07 million$82.37 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$2.522.98%+10.39%70.59%54 Years
The Beauty Health Company stock logo
SKIN
Beauty Health
N/AN/AN/AN/AN/A

Latest ABT and SKIN Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/20/2026
Abbott Laboratories stock logo
ABT
Abbott Laboratories
quarterly$0.632.48%4/15/20264/15/20265/15/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.56
1.39
1.01
The Beauty Health Company stock logo
SKIN
Beauty Health
4.37
1.79
1.48

Institutional Ownership

CompanyInstitutional Ownership
Abbott Laboratories stock logo
ABT
Abbott Laboratories
75.18%
The Beauty Health Company stock logo
SKIN
Beauty Health
93.26%

Insider Ownership

CompanyInsider Ownership
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.46%
The Beauty Health Company stock logo
SKIN
Beauty Health
40.30%
CompanyEmployeesShares OutstandingFree FloatOptionable
Abbott Laboratories stock logo
ABT
Abbott Laboratories
115,0001.74 billion1.73 billionOptionable
The Beauty Health Company stock logo
SKIN
Beauty Health
1,030129.60 million77.37 millionOptionable

Recent News About These Companies

Beauty Health (SKIN) Q1 2026 Earnings Transcript
5 beauty habits that most rich women follow for that glowing skin
Beauty Health Q1 Earnings Call Highlights

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Abbott Laboratories stock logo

Abbott Laboratories NYSE:ABT

$84.49 -0.41 (-0.49%)
Closing price 05/15/2026 03:59 PM Eastern
Extended Trading
$84.52 +0.03 (+0.04%)
As of 05/15/2026 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Beauty Health stock logo

Beauty Health NASDAQ:SKIN

$0.64 -0.03 (-4.90%)
Closing price 05/15/2026 04:00 PM Eastern
Extended Trading
$0.64 +0.00 (+0.20%)
As of 05/15/2026 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California.